Radioimmunotherapy of prostate cancer targeting human kallikrein-related peptidase 2

BACKGROUND: Prostate cancer ranks as the second most lethal malignancy in the Western world. Previous targeting of prostate-specific antigen and human kallikrein-related peptidase 2, two related enzymes abundantly expressed in prostatic malignancies, with radioimmunoconjugates intended for diagnosti...

Descripción completa

Detalles Bibliográficos
Autores principales: Vilhelmsson Timmermand, O., Larsson, E., Ulmert, D., Tran, T. A., Strand, SE.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4797400/
https://www.ncbi.nlm.nih.gov/pubmed/26983637
http://dx.doi.org/10.1186/s13550-016-0181-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4797400/
https://www.ncbi.nlm.nih.gov/pubmed/26983637
http://dx.doi.org/10.1186/s13550-016-0181-z

Ejemplares similares